ClinicalTrials.Veeva

Menu

The Duchenne Registry

T

The Duchenne Registry

Status

Enrolling

Conditions

Becker Muscular Dystrophy
Duchenne Muscular Dystrophy

Study type

Observational

Funder types

Other

Identifiers

NCT02069756
DC-PPMD-2013

Details and patient eligibility

About

The Duchenne Registry is an online, patient-report registry for individuals with Duchenne and Becker muscular dystrophy and carrier females. The purpose of the Registry is to connect Duchenne and Becker patients with actively recruiting clinical trials and research studies, and to educate patients and families about Duchenne and Becker care and research. At the same time, The Duchenne Registry is a valuable resource for clinicians and researchers in academia and industry, allowing access to de-identified datasets provided by patients and their families-information that is vital to advances in the care and treatment of Duchenne. The Duchenne Registry is a member of the TREAT-NMD Neuromuscular Network.

Full description

The Duchenne Registry (previously DuchenneConnect) was created in 2007 by Parent Project Muscular Dystrophy (PPMD), with assistance from the NIH, the CDC, and Emory Genetics. In early 2011, PPMD alone began financing the registry's operation and maintenance, and is the sole guardian of The Duchenne Registry and its material.

Questions may be addressed to the Duchenne Registry Coordinators at telephone 888-520-8675 or coordinator@duchenneregistry.org. The Duchenne Registry Coordinators are certified genetic counselors who are available to answer questions regarding the registration process, genetic testing and counseling, and clinical trials and research studies.

Enrollment

10,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Duchenne or Becker muscular dystrophy; Manifesting female carriers and asymptomatic female carriers also included in registry.

Exclusion criteria

  • Diagnosis of any other type of muscular dystrophy (including limb-girdle muscular dystrophy).

Trial design

10,000 participants in 1 patient group

Duchenne and Becker Muscular Dystrophy
Description:
Patients with Duchenne or Becker Muscular Dystrophy, as well as carrier females.

Trial contacts and locations

1

Loading...

Central trial contact

Ann Martin, MS, CGC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems